CVS Covers Weight-Loss Drugs

In a major policy reversal, CVS Caremark has announced it will begin covering Eli Lilly's blockbuster weight-loss medications, Foundayo and Zepbound.

The move is expected to significantly expand access to GLP-1 treatments for millions of Americans.

Health experts have raised concerns about the safety of online weight-loss drug sales as overdoses and hospitalizations increase.

The policy shift comes as demand for these medications continues to outpace supply across the country.